Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...

British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...

A research paper by scientists from Beijing Institute of Technology investigated the anti-tumor effect of millimeter waves ...

A father’s plastic exposure could significantly induce metabolic disorders like diabetes in offspring. Limiting the plastic ...

New research shows that a high-fat diet causes cellular damage that directly paves the way for liver cancer. The strain comes ...

Your liver cells are forgetting how to do their jobs under dietary stress. Here's how that signals cancer risk years before ...

Research into how a father’s choices — such as diet, exercise, stress, nicotine use — may transfer traits to his children has ...

Detailed price information for AI / ML Innovations Inc (AIMLF) from The Globe and Mail including charting and trades.

British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that eliminates aging. Key takeaways from special elections in Arizona and Georgia How to ...

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ...

Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...